// App-Quantinova.ai

PO1541 : Global Real-World Evidence of Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Researchers

Presenter

  • Maiese BrettA

Principal Investigators

  • Colby JenniferA

  • Pareja Kristin

  • Laplante Annick

  • Wang Xinyu

  • Mccormick Linda

  • Nourbakhsh Ali

  • Wang Tao

  • Sanon Myrlene

Medical Centers

  • Xcenda LLC Palm Harbor Florida United States

  • Otsuka Pharmaceutical Development and Commercialization Inc. Princeton New Jersey United States

  • Otsuka Canada Pharmaceutical Inc., Saint-Laurent, Quebec, Canada

  • Otsuka Pharmaceutical Europe Ltd Wexham Buckinghamshire United Kingdom

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Genetic Disorder

Disease

  • Autosomal dominant polycystic kidney disease

Biomarkers

  • N/A

Drug/Treatment

  • SAMSCA

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved